Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia

Leukemia Research

Volumn 35, Issue 11, 2011, Pages 1432-1435

  Hamblin, Terry J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

CD38; CLL; IGHV mutations; Immature laminin receptor; Prognosis; Stereotypy; ZAP 70

Indexed keywords

CD38 ANTIGEN; LAMININ RECEPTOR; PROTEIN KINASE ZAP 70;

CANCER RISK; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; FLOW CYTOMETRY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; IGHV GENE; IMMUNOGLOBULIN GENE; KARYOTYPING; LONGEVITY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SEQUENCE ANALYSIS; STEREOTYPY; SURVIVAL TIME;

ANTIGENS, CD38; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MUTATION; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 81155162591     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.07.020     Document Type: Review

References (35)

1. Damle R.N., Wasil T., Fais F., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-1847.
2. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94:1848-1854.
3. Lewis S D., Gellert M. The mechanism of antigen receptor gene assembly. Cell 1989, 59:585-588.
4. Desiderio S.V., Yancopoulos G.D., Paskind M., et al. Insertion of N regions into heavy chain genes is correlated with the expression of terminal deoxytransferase in B cells. Nature 1984, 311:752-755.
5. Corbett S.J., Tomlinson I.M., Sonnhammer E.L., Buck D., Winter G. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol 1997, 270:587-597.
6. MacLennan I.C. Germinal centers. Annu Rev Immunol 1994, 12:117-139.
7. Kipps T.J., Tomhave E., Pratt L.F., Duffey S., Chen P.P., Carson D.A. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 1989, 86:5913-5917.
8. H1 genes in human B-lineage leukaemias. Leukemia 1991, 5:646-650.
9. H3 gene families is not restricted at the level of individual genes in human chronic lymphocytic leukemia. Int Immunol 1992, 4:313-320.
10. Schroeder H.W., Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994, 15:288-294.
11. Matsuda F., Shin E.K., Nagaoka H., et al. Structural and physical map of the 64 variable segments in the 3' 0.8 megabase region of the human immunoglobulin heavy chain locus. Nat Genet 1993, 3:88-94.
12. Fais F., Ghiotto F., Hashimoto S., et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998, 102:1515-1535.
13. H genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 1997, 89:4153-4160.
14. Hamblin T.J., Davis Z., Oscier D.G., Stevenson F.K. The use of immunoglobulin heavy chain variable region genes in chronic lymphocytic leukaemia 1998, B-cell Lymphoproliferative Disorders Imedex, New York, p. 27a.
15. Hamblin T., Davis Z., Oscier D.G., Stevenson F.K. The use of immunoglobulin heavy chain variable region genes in chronic lymphocytic leukaemia. Br J Haematol 1998, 101(Suppl. 1):44a.
16. Hamblin T.J., Davies Z., Oscier D.G., Stevenson F.K. In chronic lymphocytic leukemias germline configuration of immunoglobulin heavy chain genes is associated with a more aggressive form of the disease. Blood 1998, 92(Suppl. 1):515a.
17. Hamblin T.J., Orchard J.A., Ibbotson R.E., et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002, 99:1023-1029.
18. Hamblin T. Chronic lymphocytic leukaemia: one disease or two?. Ann Hematol 2002, 81:299-303.
19. Rosenwald A., Alizadeh A.A., Widhopf G., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001, 194:1639-1647.
20. Klein U., Tu Y., Stolovitzky G.A., et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001, 194:1625-1638.
21. Crespo M., Bosch F., Villamor N., et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003, 348:1764-1775.
22. Orchard J.A., Ibbotson R.E., Davis Z., et al. ZAP-70 expression by flow cytometry is a good prognostic marker in CLL and a potential surrogate for immunoglobulin VH gene mutations. Lancet 2004, 363:105-111.
23. Rassenti L.Z., Huynh L., Toy T.L., et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004, 351:893-901.
24. Marti G., Orfao A., Goolsby C. ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue. Cytometry B Clin Cytometry 2006, 70B:197-200.
25. Codony C., Crespo N., Abrisqueta P., Montserrat E., Bosch F. Gene expression profiling in chronic lymphocytic leukaemia. Best Pract Res Clin Haematol 2009, 22:211-222.
26. Nowakowski G.S., Hoyer J.D., Shanafelt T.D., et al. Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia. J Clin Oncol 2009, 27:1844-1849.
27. Del Giudice I., Morilla A., Osuji N., et al. Zeta chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Cancer 2005, 104:2124-2132.
28. Schroers R., Griesinger F., Trumper L., et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005, 19:750-758.
29. Zucchetto A., Bomben R., Dal Bo M., et al. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia. J Cell Physiol 2006, 207:354-363.
30. Friedrichs B., Siegel S., Reimer R., et al. High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia. Leuk Res 2011, 35:721-729.
31. Hamblin T.J. ZAP-70 levels do change in CLL but not very often. Leukemia Lymphoma 2007, 48:1059-1060.
32. Agathaggelidis A., Darzentas N., Hadzidimitriou A., et al. The composition of the B cell receptor repertoire in 7428 cases of chronic lymphocytic leukemia: one third stereotyped, two thirds heterogeneous - what does this mean?. Blood 2010, 116(21):43a.
33. Stamatopoulos K., Belessi C., Moreno C., et al. Over 20% of patients with chronic lymphocytic leukaemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007, 109:259-270.
34. Tobin G., Thunberg U., Johnson A., et al. Somatically mutated IgV(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002, 99:2262-2264.
35. Rossi D., Spina V., Cerri M., et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res 2009, 15:4415-4422.